U.S. approves Moderna’s mRNA vaccine for flu—the first of its kind
This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab
This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab